AstraZeneca CEO warns that pharma may avoid launching new medicines in Europe’s largest market.
In an interview in German business paper Handelsblatt, AstraZeneca CEO Pascal Soriot reacted to proposed health reforms saying that AZ would by unable to launch some products in Germany: “It’s going to be very hard for us, we’re going to be attacked, but in the end, we will have no choice, also because of the pressure in the US.”
In March, a commission of experts presented a list of 66 cost-saving proposals to curb spiralling German healthcare costs, potentially offering policymakers a menu of measures that could reshape the country’s statutory health insurance system.
Last week, the Health Minister Nina Warken…
